Page 31 - Astrazeneca

Britain signs deals with Pfizer, BioNTech, Valneva for Covid-19 vaccines

Deals follow a previously announced agreement with AstraZeneca for the firm to produce 100 million doses of its potential vaccine being developed in partnership with the University of Oxford

Covid-19: Vaccine firms give Moderna a shrug, say no rush on tie-ups

Most players that Business Standard spoke to said they would be concentrating on their own vaccine candidates or the current tie-ups that they have

Positive news on Oxford's Covid-19 vaccine may be announced on Thursday

AstraZeneca's experimental vaccine is probably the world's leading candidate and most advanced in terms of development, the World Health Organization's chief scientist said in June

Covid-19: AstraZeneca to bring Dare-19 trial to India; 10 sites identified

Called the Dare 19 trial, it is one of the several global research efforts by the British company to find a solution to treat Covid-19

Covid-19 crisis: Race to develop vaccine gets a booster as field widens

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.

AstraZeneca says Brazil close to coronavirus vaccine deal for 100 mn doses

Brazil counts almost 58,000 dead by COVID-19, and more than 1.2 million cases of the disease

Covid-19: Brazil announces agreement with UK to produce Oxford vaccine

The Brazilian Ministry of Health announced an agreement with the UK to acquire technology to locally produce a Covid-19 vaccine currently being developed by the Oxford University and AstraZeneca

Astrazeneca leading in Covid-19 vaccine race, Moderna not far behind: WHO

Soumya Swaminathan said that Moderna's Covid-19 vaccine candidate was also not far behind Astrazeneca's, among more than 200 candidates

Sanofi eyes Covid-19 vaccine approval in early 2021; partners Translate Bio

Many drugmakers are racing to come up with a safe and effective vaccine that can be produced at large scale

Shot of Hope: Equal access a hurdle after race to coronavirus vaccine

The second of a two-part series examines challenges linked to IPR and monopoly once Covid-19 vaccine is created

Shot of Hope: Tracking the race for Covid vaccine the world is waiting for

The first of a two-part series tracks the making of vaccine that the world is waiting for

AstraZeneca Covid-19 vaccine to be shared across Europe, says France

The Netherlands also made clear on Monday that the vaccines would be available to all EU countries that sign up to the scheme after Belgium criticised the deal

AstraZeneca signs pact with EU to supply 400 mn doses of Covid-19 vaccine

It has agreed manufacturing deals globally to meet its target of producing 2 billion doses of the vaccine, including two ventures backed by Bill Gates and a $1.2 billion agreement with the US govt

AstraZeneca reaches out to rival Gilead with a merger proposal: Report

The UK-based firm informally contacted Gilead last month to gauge its interest in a possible tie-up

Serum Institute risks making Covid vaccine before trial at new $100 mn unit

AstraZeneca deal with SII is for supply of a billion doses, with a commitment to provide 400 mn before 2020-end. If all goes well, India could have its first set of Covid-19 vaccines by end of year

US secures 300 million doses of potential AstraZeneca Covid-19 vaccine

Vaccines are seen by world leaders as the only real way to restart their stalled economies.

First copies of Gilead coronavirus drug to start selling in Bangladesh

The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals

Britain's AstraZeneca to make bn Covid-19 vaccine doses if tests succeed

Drugmaker says it had signed the first agreements to supply at least 400 million doses of the vaccine, which it is developing with Oxford University.

AstraZeneca says data from Covid-19 vaccine's phase-1 trials to be out soon

Once the late stage trials begin, the company simultaneously will start working on the global manufacturing capabilities.

AstraZeneca plans to test new cancer medicine in coronavirus battle

The treatment for lymphoma may lessen the severity of respiratory distress by reducing the inflammation caused by the new coronavirus